30.01.2025 17:38:39
|
Quest Diagnostics EPS Tops Predictions
Quest Diagnostics (NYSE:DGX), a leader in diagnostic testing and information services, released its fourth quarter results on Jan. 30. The company reported a notable quarter with adjusted earnings per share (EPS) of $2.23, surpassing the analyst projection of $2.18. Additionally, revenue reached $2.62 billion, exceeding the expected $2.58 billion. Overall, Quest had a successful quarter, driven by strategic acquisitions and advancements in its diagnostics portfolio.Source: Analyst estimates for the quarter provided by FactSet.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Quest Diagnostics Inc.mehr Nachrichten
Analysen zu Quest Diagnostics Inc.mehr Analysen
Aktien in diesem Artikel
Quest Diagnostics Inc. | 163,30 | 0,25% |
|
Top's Inc. Registered Shs | 1 122,00 | 0,00% |
|